More specifically, the CD44v3-TrkA interaction is critical for breast cancer cell tumor development and metastasis in vivo, as indicated by the results showing that inhibition of TrkA/CD44v3 formation was sufficient to decrease the tumor burden and metastasis in SCID mice. Here, NTRK1 is linked to breast cancer.